Mark Schliekelman

Mark Schliekelman has extensive experience in the medical and pharmaceutical field. Mark currently holds the position of Director of Field Medical Affairs at ArteraAI since January 2023. Prior to this, they worked as a Medical Science Liaison at Adaptive Biotechnologies Corp. from May 2019 to January 2023 and at Syndax Pharmaceuticals from August 2017 to April 2019.

Mark also has experience as a Medical Science Liaison at ARIAD Pharmaceuticals, Inc. where they played a role in driving enrollment in clinical trials and increasing medical understanding of ARIAD therapeutics. Mark started their career as a Clinical Science Liaison at GenomeDx Biosciences Inc. in 2014.

Before entering the industry, Mark gained research experience as a Post-Doctoral Fellow at Fred Hutchinson Cancer Research Center, where they focused on molecular pathways and biomarkers in tumor progression. Mark also performed proteomic and genomic analyses of lung cancer cell lines, identified novel biomarker targets, and developed gene signatures for predicting lung tumor recurrence.

Mark's academic background includes being a Graduate Student at the University of North Carolina at Chapel Hill, where they studied the spindle checkpoint gene Bub1 and its relation to tumor development. Mark also worked as a Research Associate at bioMerieux, formerly Organon Teknika, where they designed assays for disease diagnostics, trained personnel, and delivered scientific presentations. Prior to that, they were a Research Associate at Organon Teknika and Novartis, where they gained experience in RNA isolation, protein extraction, and cloning techniques.

Overall, Mark Schliekelman's work experience showcases their expertise in medical and pharmaceutical research, clinical trial management, and therapeutic development.

Mark Schliekelman completed their Bachelor of Arts (B.A.) in Biology, General at Grinnell College from 1993 to 1997. Mark then pursued further education and earned their Doctor of Philosophy (Ph.D.) in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill between 2002 and 2008.